Display options
Share it on

Iran J Pharm Res. 2015;14(2):417-27.

Synthesis and Antiplatelet Aggregation Activity Evaluation of some 2-Aminopyrimidine and 2-Substituted-4,6-diaminopyrimidine Derivatives.

Iranian journal of pharmaceutical research : IJPR

Marjan Esfahanizadeh, Shohreh Mohebbi, Behnam Dasht Bozorg, Salimeh Amidi, Ali Gudarzi, Seyed Abdolmajid Ayatollahi, Farzad Kobarfard

Affiliations

  1. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Central Research Laboratories, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  2. Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  3. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  4. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  5. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ; Central Research Laboratories, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 25901148 PMCID: PMC4403057

Abstract

A series of novel 2-aminopyrimidine and 2-Substituted-4,6-diaminopyrimidine derivatives have been synthesized and their antiplatelet aggregation activities were assessed against ADP and arachidonic acid-induced platelet aggregation in human plasma using light transmission aggregometry. Among the tested derivatives, compounds Ia, Ib, IB and II16 exhibited the highest antiplatelet aggregation activity (36.75, 72.4, 62.5 and 80 µM). None of the compounds showed satisfactory activity against the aggregation induced by ADP but acceptable activities were observed against the aggregation induced by arachidonic acid. 2- aminopyrimidines were more active than 4,6- diaminopyrimidines in this respect.

Keywords: 2-Substituted-4; 2-aminopyrimidines; 6-diaminopyrimidines; Antiplatelet aggregation

References

  1. J Med Chem. 2008 Sep 25;51(18):5617-29 - PubMed
  2. Adv Ther. 2011 Jun;28(6):473-82 - PubMed
  3. Farmaco. 1999 Sep 30;54(9):588-93 - PubMed
  4. Eur J Med Chem. 2012 Jul;53:114-23 - PubMed
  5. Iran J Pharm Res. 2013 Winter;12(Suppl):91-103 - PubMed
  6. Bioorg Med Chem. 2009 Jul 1;17(13):4612-21 - PubMed
  7. Int J Cardiol. 2013 May 25;165(3):444-7 - PubMed
  8. Circulation. 2007 Apr 24;115(16):2196-207 - PubMed
  9. Br J Surg. 2000 Mar;87(3):266-72 - PubMed
  10. Chest. 2004 Sep;126(3 Suppl):234S-264S - PubMed
  11. Br J Haematol. 2008 Aug;142(4):515-28 - PubMed
  12. Am Heart J. 2011 Mar;161(3):450-61 - PubMed
  13. Circ Res. 2007 May 11;100(9):1261-75 - PubMed
  14. Chem Pharm Bull (Tokyo). 2012;60(1):70-8 - PubMed

Publication Types